United States Congress · 119 session · house
HR 10369Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026
- Status
- In committee
- Latest action
- — Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Primary sponsor
- Rep. Mackenzie, Ryan [R-PA-7] (R)
- Health
Sponsors
- Rep. Mackenzie, Ryan [R-PA-7] (R) · sponsorprimary
Versions
- Introduced in House